# Safe Use of Heparin Sodium in Patients With Chronic Renal Failure.

> **NCT01229072** · PHASE2,PHASE3 · SUSPENDED · sponsor: **Azidus Brasil** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **BIOLOGICAL:** Heparin sodic
- **BIOLOGICAL:** heparin liquemine

## Key facts

- **NCT ID:** NCT01229072
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2008-07
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01229072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01229072, "Safe Use of Heparin Sodium in Patients With Chronic Renal Failure.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01229072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*